Relentless Health Value

Dyan is the owner of a patient-focused consultancy, Inspired Health Strategies, LLC (IHS). After spending 20+ years in Big Pharma in traditional sales and marketing roles, in 2007 Dyan began working as a contractor with Sanofi. She was brought in to develop a multi-cultural marketing initiative and Dyan had little hope of making much of an impact until she realized that Sanofi was serious as evidenced by their commitment to a hefty budget and an enterprise-wide effort. She knew that, given her past experience combined with a non-traditional approach to market research, she could help Sanofi develop a groundbreaking program. What was developed was a program that incorporated the patient's ecosystem into a branded and non-branded initiative that resulted in documented behavior change and significant contribution to the bottom-line. The Community Health Partnership (CHP) changed her brain – she now understood the opportunity the industry was missing by not understanding the value of the patient. Since that Sanofi initiative Dyan has been an evangelist for patient engagement. But after years of trying to push the industry in this patient-focused direction she was ready to give up…until she attended the March 19, 2018 FDA meeting regarding the Patient-Focused Drug Development (PFDD) initiative. The FDA was going to actually issue guidance that echoes Dyan's mantra – that patients should be involved in drug development, in a meaningful way, from pre-Investigative New Drug Application (IND) through commercial. This has rejuvenated Dyan's efforts as she watches and helps the industry sort out how to comply with this guidance. Compliance will demand a change in thinking in the industry and will produce great results for patients. Dyan's efforts have been recognized by her being included in the PharmaVoice 100 Innovators in Life Sciences. Dyan has been published in several industry journals including Pharmaceutical Commerce and The Journal of Patient Adherence and is a frequent speaker at industry meetings. You can learn more about PFDD and see case studies on the work of IHS at Dyan's website www.inspiredhealthstrategies.com, follow Dyan @InspiredHealth_

I heard John Nosta say the other day that in the future, we won't be organ donors. There'll be no need if we can do a little fancy genetic work and clone a kidney. What we'll be is data donors instead. Today I'm talking about the All of Us Research Program with Edith Peterson Mitchell, MD, FACP, FCCP, professor of medicine at Thomas Jefferson University and 116th president of the National Medical Association, among her other credentials.

Edith Peterson Mitchell, MD, FACP, FCCP, is board certified in internal medicine and medical oncology and is clinical professor, Department of Medicine and Medical Oncology, at Sidney Kimmel Medical College at Thomas Jefferson University and associate director for diversity programs and director of the Center to Eliminate Cancer Disparities for the Sidney Kimmel Cancer Center at Thomas Jefferson University. Dr. Mitchell's research in breast, colorectal, and pancreatic cancers and other GI malignancies involves new drug evaluation and chemotherapy, development of new therapeutic regimens, chemoradiation strategies for combined modality therapy, patient selection criteria, and supportive care for patients with gastrointestinal cancer. She has spent her medical career assisting individuals in medically underserved areas realize that changes in lifestyle can dramatically impact cancer care. Through her work, Dr. Mitchell has demonstrated the importance of community service and outreach, especially to individuals unable to obtain more conventional medical advice. Dr. Mitchell holds leadership positions in the American Society of Clinical Oncology (ASCO), serves on the National Cancer Institute (NCI) Review Panel, the Cancer Investigations Review Committee, the Clinical Trials and Translational Research Advisory Committee, and the National Institutes of Health (NIH) Council of Councils; is co-chair of the NCI Disparities Committee; and served on the NCI's Blue Ribbon Panel. She was the 116th president of the National Medical Association. Dr. Mitchell is also a retired United States Air Force Brigadier General, having served in the Air National Guard. You can learn more by going to joinallofus.org, or visit their Twitter profile @allofusresearch, #joinallofus.

Alex is a partner/managing director in Parthenon-EY, where she works primarily on growth strategy projects. She helps clients define and implement their strategy and build organizational capabilities to deliver sustainable business results through both organic and inorganic approaches. She is a thought leader in the industry and specializes in asset repurposing and optimizing value propositions. Prior to joining EY, she was the senior vice president of Walgreens Corporate Strategy. Alex has over 30 years of experience working on strategic growth and risk mitigation engagements. She began her career with Arthur Andersen and after 10 years moved into consulting with Mercer as the leader of the National Health Care Analysis Unit, helping to architect one of the first health data analytics platforms. Alex has worked globally with Fortune 500 companies and has developed and implemented large-scale strategy, operations, and financial projects. Her domain expertise in health care and life sciences includes hospital operations, pharmacy and drug manufacturing, patient clinical intervention programs, employer benefit plan designs and funding, commercialization, and growth strategies, including mergers and acquisitions. Alex has been quoted in numerous articles in Forbes, the Chicago Tribune, Business Insurance, Workforce Management magazine, Crain's Chicago Business, and other industry publications. She is on the editorial board of Inside Patient Care magazine. 01:00 Why change is coming. 01:30 More convergence coming to the industry. 02:20 The interlopers—private equity firms. 02:35 Challenging perverse incentives. 04:20 What HMOs used to be, and why they were the dominant health insurance policy design. 05:45 Why so many HMOs went bankrupt. 06:20 How we might see social advocacy change health care yet again.

Alex is a partner/managing director in Parthenon-EY, where she works primarily on growth strategy projects. She helps clients define and implement their strategy and build organizational capabilities to deliver sustainable business results through both organic and inorganic approaches. She is a thought leader in the industry and specializes in asset repurposing and optimizing value propositions. Prior to joining EY, she was the senior vice president of Walgreens Corporate Strategy.

Alex has over 30 years of experience working on strategic growth and risk mitigation engagements. She began her career with Arthur Andersen and after 10 years moved into consulting with Mercer as the leader of the National Health Care Analysis Unit, helping to architect one of the first health data analytics platforms.

Alex has worked globally with Fortune 500 companies and has developed and implemented large-scale strategy, operations, and financial projects. Her domain expertise in health care and life sciences includes hospital operations, pharmacy and drug manufacturing, patient clinical intervention programs, employer benefit plan designs and funding, commercialization, and growth strategies, including mergers and acquisitions.

Alex has been quoted in numerous articles in Forbes, the Chicago Tribune, Business Insurance, Workforce Management magazine, Crain’s Chicago Business, and other industry publications. She is on the editorial board of Inside Patient Care magazine.

01:00 Why change is coming. 01:30 More convergence coming to the industry. 02:20 The interlopers—private equity firms. 02:35 Challenging perverse incentives. 04:20 What HMOs used to be, and why they were the dominant health insurance policy design. 05:45 Why so many HMOs went bankrupt. 06:20 How we might see social advocacy change health care yet again.

Don is an accomplished Health IT expert with a 20-year track record of driving value with technology.

Don began his career as a custom software developer and eventually built and lead a team of more than 30 engineers. Later he was a subject matter expert, product manager and head of sales and marketing for a digital health startup that launched a SaaS-platform focused on administrative simplification in health care.

Today, Don is president of Glide Health IT, LLC, a consulting firm that helps forward-looking organizations align their health IT and business strategies. The firm specializes in business and product development with a focus on data aggregation, interop, analytics and quality measurement.

Don is also the founder, co-host and executive producer of The #HCBiz Show!, a podcast dedicated to unraveling the business of health care.

When not hosting the show, Stacey is co-president of Aventria Health Group, a marketing agency and consultancy. Aventria specializes in helping pharmaceutical, employer, pharmacy, and health system clients improve patient outcomes by creating and leveraging collaborations with other health care organizations. For more than 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and, most of all, the patient.

Learn more about Don Lee and The #HCBiz Show!, a podcast at thehcbiz.com or by following Don on twitter @dflee30.

Don is an accomplished Health IT expert with a 20-year track record of driving value with technology. Don began his career as a custom software developer and eventually built and lead a team of more than 30 engineers. Later he was a subject matter expert, product manager and head of sales and marketing for a digital health startup that launched a SaaS-platform focused on administrative simplification in health care. Today, Don is president of Glide Health IT, LLC, a consulting firm that helps forward-looking organizations align their health IT and business strategies. The firm specializes in business and product development with a focus on data aggregation, interop, analytics and quality measurement. Don is also the founder, co-host and executive producer of The #HCBiz Show!, a podcast dedicated to unraveling the business of health care. When not hosting the show, Stacey is co-president of Aventria Health Group, a marketing agency and consultancy. Aventria specializes in helping pharmaceutical, employer, pharmacy, and health system clients improve patient outcomes by creating and leveraging collaborations with other health care organizations. For more than 20 years, Stacey has innovated better-coordinated health solutions benefiting all stakeholders, and, most of all, the patient. Learn more about Don Lee and The #HCBiz Show!, a podcast at thehcbiz.com or by following Don on twitter @dflee30.

John Gorman is founder and executive chairman at Gorman Health Group (GHG). In this role, he has led the development of the industry’s leading consulting practice and several entrepreneurial ventures in government health programs. John’s work focuses on Medicare, Medicaid, and Affordable Care Act strategy, governance, and turnaround of distressed health plans. Prior to founding the firm, John served as assistant to the director of Health Care Financing Administration’s Office of Managed Care, where he provided day-to-day management and served as the external liaison for the Medicare and Medicaid managed care programs. During the 1993 debate on national health care reform, John was chief lobbyist on health care financing issues for the National Association of Community Health Centers, an organization of federally funded primary care clinics for the medically underserved. John’s career in Washington began as press secretary and staff director for US Representative John Conyers, Jr (D-MI), then chairman of the Government Operations Committee.

00:19 How Pharma and suppliers to providers are being impacted by needing to produce outcomes. 00:31 Future huge sources of revenue for manufacturers. 00:37 Cutting out the PBM. 01:28 “They are basically rebate machines.”—John 02:23 “How far do you want to push the disruption of your biggest customers?”—Stacey 02:36 “All they’re going to have to do is wait a couple years.”—John 04:03 Getting away from rebates and into a different business model altogether. 05:13 “It’s not skin in the game, and it’s not a game—this is people’s health care.”—John 06:40 EP189 with Alex Jung of Ernst & Young.

John Gorman is founder and executive chairman at Gorman Health Group (GHG). In this role, he has led the development of the industry's leading consulting practice and several entrepreneurial ventures in government health programs. John's work focuses on Medicare, Medicaid, and Affordable Care Act strategy, governance, and turnaround of distressed health plans. Prior to founding the firm, John served as assistant to the director of Health Care Financing Administration's Office of Managed Care, where he provided day-to-day management and served as the external liaison for the Medicare and Medicaid managed care programs. During the 1993 debate on national health care reform, John was chief lobbyist on health care financing issues for the National Association of Community Health Centers, an organization of federally funded primary care clinics for the medically underserved. John's career in Washington began as press secretary and staff director for US Representative John Conyers, Jr (D-MI), then chairman of the Government Operations Committee. 00:19 How Pharma and suppliers to providers are being impacted by needing to produce outcomes. 00:31 Future huge sources of revenue for manufacturers. 00:37 Cutting out the PBM. 01:28 "They are basically rebate machines."—John 02:23 "How far do you want to push the disruption of your biggest customers?"—Stacey 02:36 "All they're going to have to do is wait a couple years."—John 04:03 Getting away from rebates and into a different business model altogether. 05:13 "It's not skin in the game, and it's not a game—this is people's health care."—John 06:40 EP189 with Alex Jung of Ernst & Young.

The US Department of Health and Human Services defines telehealth as "the use of electronic information and telecommunications technologies to support and promote long-distance clinical health care, patient and professional health-related education, public health and health administration." Today I speak with Nate Lacktman, a partner at the law firm of Foley & Lardner LLP and chair of the firm’s Telemedicine Industry Team, about telehealth goings-on that you in the industry really should know about.